Lucie Heinzerling

11PUBLICATIONS
109CO-AUTHORS
Molecular targetsChemotherapyAutoimmunityInnate immunityGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 26, 2025
Immune checkpoint inhibitor-associated myocarditis: a novel risk score.

John R Power, Charles Dolladille, Benay Ozbay

|Mar 19, 2025
Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma.

Reinhard Dummer, Shahneen Sandhu, Wilson H Miller

Pageof 2